| N-terminal domain antigenic mapping reveals a site of vulnerability for SARS-CoV-2 M McCallum, A De Marco, FA Lempp, MA Tortorici, D Pinto, AC Walls, ... Cell 184 (9), 2332-2347. e16, 2021 | 848 | 2021 |
| Hepatitis B and D viruses exploit sodium taurocholate co-transporting polypeptide for species-specific entry into hepatocytes YI Ni, FA Lempp, S Mehrle, S Nkongolo, C Kaufman, M Fälth, J Stindt, ... Gastroenterology 146 (4), 1070-1083. e6, 2014 | 820 | 2014 |
| Ultrapotent human antibodies protect against SARS-CoV-2 challenge via multiple mechanisms MA Tortorici, M Beltramello, FA Lempp, D Pinto, HV Dang, LE Rosen, ... Science 370 (6519), 950-957, 2020 | 503 | 2020 |
| Treatment of chronic hepatitis D with the entry inhibitor myrcludex B: First results of a phase Ib/IIa study P Bogomolov, A Alexandrov, N Voronkova, M Macievich, K Kokina, ... Journal of hepatology 65 (3), 490-498, 2016 | 438 | 2016 |
| SARS-CoV-2 RBD antibodies that maximize breadth and resistance to escape TN Starr, N Czudnochowski, Z Liu, F Zatta, YJ Park, A Addetia, D Pinto, ... Nature 597 (7874), 97-102, 2021 | 376 | 2021 |
| Cyclosporin A inhibits hepatitis B and hepatitis D virus entry by cyclophilin-independent interference with the NTCP receptor S Nkongolo, Y Ni, FA Lempp, C Kaufman, T Lindner, K Esser-Nobis, ... Journal of hepatology 60 (4), 723-731, 2014 | 282 | 2014 |
| Broad betacoronavirus neutralization by a stem helix–specific human antibody D Pinto, MM Sauer, N Czudnochowski, JS Low, MA Tortorici, MP Housley, ... Science 373 (6559), 1109-1116, 2021 | 277 | 2021 |
| Lectins enhance SARS-CoV-2 infection and influence neutralizing antibodies FA Lempp, LB Soriaga, M Montiel-Ruiz, F Benigni, J Noack, YJ Park, ... Nature 598 (7880), 342-347, 2021 | 243 | 2021 |
| The dual function monoclonal antibodies VIR-7831 and VIR-7832 demonstrate potent in vitro and in vivo activity against SARS-CoV-2 AL Cathcart, C Havenar-Daughton, FA Lempp, D Ma, MA Schmid, ... biorxiv, 2021.03. 09.434607, 2021 | 203 | 2021 |
| Broad sarbecovirus neutralization by a human monoclonal antibody MA Tortorici, N Czudnochowski, TN Starr, R Marzi, AC Walls, F Zatta, ... Nature 597 (7874), 103-108, 2021 | 201 | 2021 |
| Hepatitis delta virus: insights into a peculiar pathogen and novel treatment options FA Lempp, Y Ni, S Urban Nature reviews Gastroenterology & hepatology 13 (10), 580-589, 2016 | 166 | 2016 |
| Impaired uptake of conjugated bile acids and hepatitis b virus pres1‐binding in na+‐taurocholate cotransporting polypeptide knockout mice D Slijepcevic, C Kaufman, CGK Wichers, EH Gilglioni, FA Lempp, S Duijst, ... Hepatology 62 (1), 207-219, 2015 | 160 | 2015 |
| HBV bypasses the innate immune response and does not protect HCV from antiviral activity of interferon P Mutz, P Metz, FA Lempp, S Bender, B Qu, K Schöneweis, S Seitz, T Tu, ... Gastroenterology 154 (6), 1791-1804. e22, 2018 | 158 | 2018 |
| Imprinted antibody responses against SARS-CoV-2 Omicron sublineages YJ Park, D Pinto, AC Walls, Z Liu, A De Marco, F Benigni, F Zatta, ... Science 378 (6620), 619-627, 2022 | 150 | 2022 |
| Predicting the mutational drivers of future SARS-CoV-2 variants of concern MC Maher, I Bartha, S Weaver, J Di Iulio, E Ferri, L Soriaga, FA Lempp, ... Science translational medicine 14 (633), eabk3445, 2022 | 128 | 2022 |
| Antibody-mediated broad sarbecovirus neutralization through ACE2 molecular mimicry YJ Park, A De Marco, TN Starr, Z Liu, D Pinto, AC Walls, F Zatta, ... Science 375 (6579), 449-454, 2022 | 107 | 2022 |
| Sodium taurocholate cotransporting polypeptide is the limiting host factor of hepatitis B virus infection in macaque and pig hepatocytes FA Lempp, E Wiedtke, B Qu, P Roques, I Chemin, FWR Vondran, ... Hepatology 66 (3), 703-716, 2017 | 99 | 2017 |
| Inhibitors of hepatitis B virus attachment and entry FA Lempp, S Urban Intervirology 57 (3-4), 151-157, 2014 | 94 | 2014 |
| Evidence that hepatitis B virus replication in mouse cells is limited by the lack of a host cell dependency factor FA Lempp, P Mutz, C Lipps, D Wirth, R Bartenschlager, S Urban Journal of hepatology 64 (3), 556-564, 2016 | 87 | 2016 |
| Evaluation of cell-based and surrogate SARS-CoV-2 neutralization assays AM Sholukh, A Fiore-Gartland, ES Ford, MD Miner, YJ Hou, LV Tse, ... Journal of Clinical Microbiology 59 (10), 10.1128/jcm. 00527-21, 2021 | 79 | 2021 |
Stephan UrbanFull Professor for translational Virology, University of HeidelbergVerified email at med.uni-heidelberg.de
